Literature DB >> 18988879

Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?

Carlo Giannini, Laura Gragnani, Alessia Piluso, Patrizio Caini, Antonio Petrarca, Monica Monti, Giacomo Laffi, Anna Linda Zignego.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988879     DOI: 10.1182/blood-2008-07-170613

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.

Authors:  Mona Wagdy Ayad; Amany A Elbanna; Dalia A Elneily; Amany S Sakr
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

2.  B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.

Authors:  G Lake-Bakaar; I Jacobson; A Talal
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 3.  Hepatitis C virus-induced cryoglobulinemia.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

Review 4.  The hepatitis C virus infection as a systemic disease.

Authors:  Anna Linda Zignego; Laura Gragnani; Carlo Giannini; Giacomo Laffi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 5.  Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?

Authors:  Laura Gragnani; Elisa Fognani; Alessia Piluso; Anna Linda Zignego
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 6.  New insights into HCV-related rheumatologic disorders: A review.

Authors:  Patrice Cacoub; Cloé Comarmond
Journal:  J Adv Res       Date:  2016-07-25       Impact factor: 10.479

7.  Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases.

Authors:  Laura Gragnani; Elisa Fognani; Valli De Re; Massimo Libra; Adriana Garozzo; Patrizio Caini; Guia Cerretelli; Andrea Giovannelli; Serena Lorini; Monica Monti; Silvia Bagnoli; Irene Piaceri; Anna Linda Zignego
Journal:  Oncotarget       Date:  2017-05-06

Review 8.  HCV and lymphoproliferation.

Authors:  Anna Linda Zignego; Carlo Giannini; Laura Gragnani
Journal:  Clin Dev Immunol       Date:  2012-07-19

9.  Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.

Authors:  Tsai-Ling Liao; Yi-Ming Chen; Shie-Liang Hsieh; Kuo-Tung Tang; Der-Yuan Chen; Ying-Ying Yang; Hung-Jen Liu; Sheng-Shun Yang
Journal:  mBio       Date:  2021-11-02       Impact factor: 7.867

10.  Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.

Authors:  Laura Gragnani; Serena Lorini; Silvia Marri; Umberto Basile; Veronica Santarlasci; Monica Monti; Francesco Madia; Luisa Petraccia; Cristina Stasi; Niccolò Marello; Cecilia Napodano; Francesco Annunziato; Anna Linda Zignego
Journal:  Hepatology       Date:  2021-05-26       Impact factor: 17.425

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.